Abstract
Gastrointestinal complications of diabetes mellitus are common if diabetes is not treated properly. About 30% of patients with long-standing diabetes and chronic hyperglycemia have diabetic autonomic neuropathy, which can affect the enteric nervous system. In addition to diabetic autonomic neuropathy with sensory-motor disturbances, diabetes causes histomorphological and biomechanical gastrointestinal tract remodeling that affects all layers of the colon wall. Proposed mechanisms are hyperglycemia-induced increased expression of advanced glycation end-products (AGE) and their receptors (RAGE) in the intestinal wall, and oxidative stress. The whole gastrointestinal tract may be affected, and we can expect motility disorder, abnormal secretion, absorption, and transportation. Clinical consequences of colon engagement are diarrhea, constipation, fecal incontinence, and alternation, or a combination of these symptoms. Although gastrointestinal complications of diabetes mellitus are common, physicians still do not think enough about them.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Drewes AM, Søfteland E, Dimcevski G, Farmer AD, Brock C, Frøkjær JB, et al. Brain changes in diabetes mellitus patients with gastrointestinal symptoms. World J Diabetes. 2016;7:14–26.
Maisey A. A practical approach to gastrointestinal complications of diabetes. Diabetes Ther. 2016;7:379.
Gould M, Sellin JH. Diabetic diarrhea. Curr Gastroenterol Rep. 2009;11:354.
Shakil A, Church RJ, Rao SS. Gastrointestinal complications of diabetes. Am Fam Physician. 2008;77:1697–702.
Frokjaer JB, Andersen SD, Ejskjaer N, Funch-Jensen P, Drewes AM, Gregersen H. Impaired contractility and remodeling of the upper gastrointestinal tract in diabetes mellitus type-1. World J Gastroenterol. 2007;13:4881–90.
Brock C, Søfteland E, Gunterberg V, Frøkjær JB, Lelic D, Brock B, et al. Diabetic autonomic neuropathy affects symptom generation and brain–gut axis. Diabetes Care. 2013;36:3698–705.
Yarandi SS, Srinivasan S. Diabetic gastrointestinal motility disorders and the role of enteric nervous system: current status and future directions. Neurogastroenterol Motil. 2014;26:611–24.
Zhao J, Frøkjaer JB, Drewes AM, Ejskjaer N. Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus. World J Gastroenterol. 2006;12:2846–57.
Zhao J, Nakaguchi T, Gregersen H. Biomechanical and histomorphometric colon remodelling in STZ-induced diabetic rats. Dig Dis Sci. 2009;54:1636–42.
Furness JB, Callaghan BP, Rivera LR, Cho HJ. The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv Exp Med Biol. 2014;817:39–71.
Rumessen JJ. Identification of interstitial cells of Cajal. Significance for studies of human small intestine and colon. Dan Med Bull. 1994;41:275–93.
Wang XY, Huizinga JD, Diamond J, Liu LW. Loss of intramuscular and submuscular interstitial cells of Cajal and associated enteric nerves is related to decreased gastric emptying in streptozotocin-induced diabetes. Neurogastroenterol Motil. 2009;21:1095–e92.
Zhao M, Liao D, Zhao J. Diabetes-induced mechanophysiological changes in the small intestine and colon. World J Diabetes. 2017;8(6):249–69.
Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl). 2005;83:876–86.
Yamagishi S, Fukami K, Matsui T. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications. Cardiovasc Diabetol. 2015;14:2.
Monnier VM, Sell DR, Nagaraj RH, Miyata S, Grandhee S, Odetti P, Ibrahim SA. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes. 1992;41(Suppl 2):36–41.
Reddy GK. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res. 2004;68:132–42.
Siegman MJ, Eto M, Butler TM. Remodeling of the rat distal colon in diabetes: function and ultrastructure. Am J Physiol Cell Physiol. 2016;310:151–60.
Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. Proc Natl Acad Sci U S A. 1981;78:5190–2.
Piper MS, Saad RJ. Diabetes mellitus and the colon. Curr Treat Options Gastroenterol. 2017;15(4):460–74.
Chen P, Zhao J, Gregersen H. Up-regulated expression of advanced glycation end-products and their receptor in the small intestine and colon of diabetic rats. Dig Dis Sci. 2012;57:48–57.
Zoubi SA, Mayhew TM, Sparrow RA. The small intestine in experimental diabetes: cellular adaptation in crypts and villi at different longitudinal sites. Virchows Arch. 1995;426:501–7.
Chandrasekharan B, Anitha M, Blatt R, et al. Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2011;23(2):131–e26.
Sekido H, Suzuki T, Jomori T, Takeuchi M, Yabe-Nishimura C, Yagihashi S. Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells. Biochem Biophys Res Commun. 2004;320:241–8.
A G, Papanas N, Maltezos E. Diabetic gastrointestinal autonomic neuropathy: current status and new achievements for everyday clinical practice. Eur J Intern Med. 2012;23(6):499–505.
Iber FL, Parveen S, Vandrunen M, Sood KB, Reza F, Serlovsky R, Reddy S. Relation of symptoms to impaired stomach, small bowel, and colon motility in long-standing diabetes. Dig Dis Sci. 1993;38:45–50.
Sims MA, Hasler WL, Chey WD, Kim MS, Owyang C. Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans. Gastroenterology. 1995;108:350–9.
Battle WM, Snape WJ, Alavi A, Cohen S, Braunstein S. Colonic dysfunction in diabetes mellitus. Gastroenterology. 1980;79:1217–21.
Malago JJ. Contribution of microbiota to the intestinal physicochemical barrier. Benef Microbes. 2015;6(3):295–311.
Dooley CP, Bargen JA, Bellman JL, et al. The “diarrhea of diabetes” and steatorrhea of pancreatic insufficiency. Mayo Clin Proc. 1936;11:737–42.
Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs. 2005;65(3):385–411.
Lysy J, Israeli E, Goldin E. The prevalence of chronic diarrhea among diabetic patients. Am J Gastroenterol. 1999;94:2165–70.
Schiller RL, Sellin HJ. Diarrhea. In: Lawrence RS, Sleisenger MH, Feldman M, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease: pathophysiology, diagnosis, management. Philadelphia: Saunders/Elsevier; 2010. p. 211–232.
S S. Evaluating the patient with diarrhea: a case-based approach. Mayo Clin Proc. 2012;87(6):596–602.
Vanner S. The lactulose breath test for diagnosing SIBO in IBS patients: another nail in the coffin. Am J Gastroenterol. 2008;103:96465.
Ritz V, Alfalah M, Zimmer KP, Schmitz J, Jacob R, Naim HY. Congenital sucrase–isomaltase deficiency because of an accumulation of the mutant enzyme in the endoplasmic reticulum. Gastroenterology. 2003;125(6):1678–85.
Cézard JP, Broyart JP, Cuisinier-Gleizes P, Mathieu H. Sucrase–isomaltase regulation by dietary sucrose in the rat. Gastroenterology. 1983;84(1):18–25.
Rodolosse A, Chantret I, Lacasa M, Chevalier G, Zweibaum A, Swallow D, et al. A limited upstream region of the human sucrase–isomaltase gene confers glucose-regulated expression on a heterologous gene. Biochem J. 1996;315(Pt 1):301–6.
Lee TH, Lee JS. Ramosetron might be useful for treating diabetic diarrhea with a rapid small bowel transit time. Korean J Intern Med. 2013;28:106–7.
Chandran M, Chu NV, Edelman SV. Gastrointestinal disturbances in diabetes. Curr Diab Rep. 2003;3(1):43–8.
Brandt LJ, Prather CM, Quigley EM, Schiller LR, Schoenfeld P, Talley NJ. Systematic review on the management of chronic constipation in North America. Am J Gastroenterol. 2005;100(Suppl 1):S5–S21.
Sandler RS, Drossman DA. Bowel habits in young adults not seeking health care. Dig Dis Sci. 1987;32(8):841–5.
Wald A. Etiology and evaluation of chronic constipation in adults. Talley NJ, ed. UpToDate Inc. http://www.uptodate.com. Accessed May 2016.
Drossman DA, Hasler WL. Rome IV—functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257–1261.
Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99(4):750–9.
Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med. 1983;98(3):378–84.
Mjornheim AC, Finizia C, Blohme G, Attvall S, Lundell L, Ruth M. Gastrointestinal symptoms in type 1 diabetic patients, as compared to a general population. A questionnaire-based study. Digestion. 2003;68:102–8.
Sellin JH, Chang EB. Therapy insight: gastrointestinal complications of diabetes—pathophysiology and management. Nat Clin Pract Gastroenterol Hepatol. 2008;5(3):162–71.
Talley NJ, Fleming KC, Evans JM, O'Keefe EA, Weaver AL, Zinsmeister AR, Melton LJ 3rd. Constipation in an elderly community: a study of prevalence and potential risk factors. Am J Gastroenterol. 1996;91(1):19–25.
Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol. 1989;84:868–72.
Maleki D, Locke GR, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808–16.
Andrews CN, Storr M. The pathophysiology of chronic constipation. Can J Gastroenterol. 2011;25(Suppl B):16B–21B.
Consoli A. Potential side effects to GLP-1 agonists: understanding their safety and tolerability. Expert Opin Drug Saf. 2015;14(2):207–18.
Fenofibrate 267 mg Capsules—summary of product characteristics. http://www.medicines.org.uk/emc/medicine/22425/SPC. Accessed May 2016
Robson KM, Lembo AJ. Fecal incontinence in adults: etiology and evaluation. Talley NJ, ed. UpToDate Inc. http://www.uptodate.com. Accessed 6 Sept 2017
Nelson RL. Epidemiology of fecal incontinence. Gastroenterology. 2004;126(1 Suppl):S3–7.
Deffieux X, Raibaut P, Rene-Corail P, Katz R, Perrigot M, Ismael SS, et al. External anal sphincter contraction during cough: not a simple spinal reflex. Neurourol Urodyn. 2006;25(7):782–7.
Krishnan B, Babu S, Walker J, Walker AB, Pappachan JM. Gastrointestinal complications of diabetes mellitus. World J Diabetes. 2013;4(3):51–63. https://doi.org/10.4239/wjd.v4.i3.51.
Zhao J, Chen P, Gregersen H. Morpho-mechanical intestinal remodeling in type 2 diabetic GK rats—is it related to advanced glycation end product formation? J Biomech. 2013;46:1128–34.
Schiller LR, Santa Ana CA, Schmulen AC, Hendler RS, Harford WV, Fordtran JS. Pathogenesis of fecal incontinence in diabetes mellitus: evidence for internal-anal-sphincter dysfunction. N Engl J Med. 1982;307(27):1666–71.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Bišćanin, A. (2018). Clinical Manifestations. In: Duvnjak, M., Smirčić-Duvnjak, L. (eds) Gastrointestinal Complications of Diabetes . Clinical Gastroenterology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-75856-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-75856-5_13
Published:
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-75855-8
Online ISBN: 978-3-319-75856-5
eBook Packages: MedicineMedicine (R0)